PL337201A1 - Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione - Google Patents

Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione

Info

Publication number: PL337201A1
Authority: PL; Poland
Prior art keywords: triazinolydino; dione; pyridyl; benzyl; methyl
Prior art date: 1997-06-05

Application number

PL98337201A

Other languages

English (en)

Inventor

Jai Patel

Hamish Ross

Jeffrey Roger Granett

Robin Price

Paul Nigel Wray

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2000-08-14

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc

2000-08-14 Publication of PL337201A1 publication Critical patent/PL337201A1/xx

Links

125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

PL98337201A 1997-06-05 1998-06-02 Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione PL337201A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition

Publications (1)

Publication Number	Publication Date
PL337201A1 true PL337201A1 (en)	2000-08-14

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL98337201A PL337201A1 (en)	1997-06-05	1998-06-02	Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (id)
JP (1)	JP2001521553A (id)
KR (1)	KR20010013410A (id)
CN (3)	CN1112926C (id)
AP (1)	AP1214A (id)
AR (2)	AR008198A1 (id)
AU (1)	AU8215098A (id)
BG (1)	BG104048A (id)
BR (1)	BR9810405A (id)
CA (2)	CA2333352A1 (id)
CO (1)	CO4940400A1 (id)
DZ (1)	DZ2510A1 (id)
EA (1)	EA002384B1 (id)
GB (1)	GB9711683D0 (id)
HU (1)	HUP0004070A3 (id)
ID (1)	ID24264A (id)
IL (1)	IL133074A0 (id)
MX (1)	MXPA99011322A (id)
NO (2)	NO995938L (id)
NZ (2)	NZ523725A (id)
OA (1)	OA11306A (id)
PE (1)	PE78899A1 (id)
PL (1)	PL337201A1 (id)
SK (1)	SK164899A3 (id)
TR (2)	TR200002790T2 (id)
TW (1)	TW570797B (id)
UY (1)	UY25032A1 (id)
WO (1)	WO1998055122A1 (id)
ZA (2)	ZA984826B (id)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
AR023561A1 (es) *	1999-04-23	2002-09-04	Smithkline Beecham Corp	Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
HRP20010773B1 (en)	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
ES2294980T1 (es) *	2006-05-09	2008-04-16	Teva Pharmaceutical Industries Ltd.	Acido 2-n-(5-((4-(2-(metil-2-piridinilamino)etoxi)fenil)metil)-2,4-tiazolidindiona)-butanodioico, procedimientos de preparacion y composiciones con maleato de rosiglitazona.
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
JPH11510508A (ja) *	1995-08-10	1999-09-14	ワーナー−ランバート・コンパニー	インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法
WO1997018811A1 (en) *	1995-11-17	1997-05-29	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
AU3552697A (en) *	1996-07-12	1998-02-09	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Ceased
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/ko not_active Ceased
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/xx active
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2292629C (en)	2004-01-06
MXPA99011322A (es)	2004-12-02
BG104048A (bg)	2000-07-31
EA002384B1 (ru)	2002-04-25
NO20040738L (no)	2000-02-02
EA199901116A1 (ru)	2000-06-26
NO995938D0 (no)	1999-12-03
NO995938L (no)	2000-02-02
AR015120A1 (es)	2001-04-18
NZ513922A (en)	2001-09-28
AR008198A1 (es)	1999-12-29
TW570797B (en)	2004-01-11
AU8215098A (en)	1998-12-21
WO1998055122A1 (en)	1998-12-10
BR9810405A (pt)	2000-08-29
JP2001521553A (ja)	2001-11-06
KR20010013410A (ko)	2001-02-26
CN1259050A (zh)	2000-07-05
NZ523725A (en)	2004-09-24
HUP0004070A2 (hu)	2002-02-28
CA2292629A1 (en)	1998-12-10
CN1526391A (zh)	2004-09-08
CA2333352A1 (en)	1998-12-10
GB9711683D0 (en)	1997-08-06
CN1112926C (zh)	2003-07-02
ZA984826B (en)	1999-08-03
TR200002790T2 (tr)	2001-11-21
CO4940400A1 (es)	2000-07-24
HUP0004070A3 (en)	2002-03-28
IL133074A0 (en)	2001-03-19
TR199902963T2 (xx)	2000-02-21
DZ2510A1 (fr)	2003-01-25
PE78899A1 (es)	1999-10-22
ID24264A (id)	2000-07-13
OA11306A (en)	2003-10-22
ZA9811572B (en)	1999-07-22
CN1430959A (zh)	2003-07-23
AP1214A (en)	2003-10-08
SK164899A3 (en)	2000-11-07
AP9901696A0 (en)	1999-12-31
EP0998284A1 (en)	2000-05-10
UY25032A1 (es)	1998-11-26

Publication	Publication Date	Title
WO2000017190A3 (fr)	2000-10-26	Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU8441798A (en)	1999-02-10	Tricyclically substituted oxazolidinones
PL341146A1 (en)	2001-03-26	Maleic 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolydin-2,4-dione salt hydrate as a pharmacological agent
AUPP003197A0 (en)	1997-11-20	New heterocyclic compounds
IL146111A0 (en)	2002-07-25	5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
IL133074A0 (en)	2001-03-19	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
AU7907498A (en)	1999-01-19	Novel heterocyclic compounds
PL341147A1 (en)	2001-03-26	Maleic 5-[4-[2[(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl}thiazolydin-2,4-dione salt hydrate
NO2009002I1 (no)	2009-03-02	5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid
AU7907298A (en)	1999-01-19	Novel heterocyclic compounds
ZA984795B (en)	1999-01-04	New thiazolidinedione oxazolidinedione and oxadiazolidinedione derivatives
ZA972973B (en)	1997-11-03	Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
AU2231397A (en)	1997-09-22	Thiazolidine-2,4-dione derivatives
AU6291098A (en)	1998-09-29	Novel heterocyclic compounds
AU4167099A (en)	2000-01-05	Heterocyclic compounds as hypoglycemic agents
IL125453A0 (en)	1999-03-12	4-(Benzo-1,3-dioxylyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
HUP0003710A3 (en)	2002-01-28	2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl]propylmercapto}pyrimidin-4-ol-fumarate and pharmaceutical composition containing this compound
IL160144A0 (en)	2004-06-20	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
MXPA03001956A (es)	2003-06-24	La sal de clorhidrato de 5-[4-[2-(n-metil, -n-metil-n -(2-piridil) amino) etoxi] bencil] tiazolidin-2, 4-diona.
HU9802874D0 (en)	1999-02-01	Process for making 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate
AUPO622597A0 (en)	1997-05-08	New heterocyclic compounds
PL354991A1 (en)	2004-03-22	Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
AU8440498A (en)	1999-02-08	5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives
AU5437398A (en)	1999-03-01	Improved hand-held container for predissolving detergent composition
AUPO527597A0 (en)	1997-03-20	Novel heterocyclic compounds